Difference between revisions of "Team:SZU China/Practices"

Line 234: Line 234:
 
</li>
 
</li>
 
<li>
 
<li>
−
<time class="cbp_tmtime" datetime="2013-04-11T12:04"><span>April 28th -</span> <span> June 20th</span></time>
+
−
<div class="cbp_tmicon cbp_tmicon-screen"></div>
+
 
<div class="cbp_tmlabel">
 
<div class="cbp_tmlabel">
 
 
Line 242: Line 241:
 
</li>
 
</li>
 
<li>
 
<li>
−
<time class="cbp_tmtime" datetime="2013-04-13 05:36"><span>June 26th-</span> <span> June 26th</span></time>
+
−
<div class="cbp_tmicon cbp_tmicon-mail"></div>
+
 
<div class="cbp_tmlabel">
 
<div class="cbp_tmlabel">
 
<p>Transfected the two plasmid system in 5637 and T24 bladder cancer cells,and got a good result in Rluc(with amber mutation). Moreover,we got the control experiments data in human bladder fiber epithelial normal cells(HFC).</p>
 
<p>Transfected the two plasmid system in 5637 and T24 bladder cancer cells,and got a good result in Rluc(with amber mutation). Moreover,we got the control experiments data in human bladder fiber epithelial normal cells(HFC).</p>
Line 256: Line 254:
 
</li>
 
</li>
 
<li>
 
<li>
−
<time class="cbp_tmtime" datetime="2013-04-16 21:30"><span>July 10th-</span> <span>July 25th</span></time>
+
−
<div class="cbp_tmicon cbp_tmicon-earth"></div>
+
 
<div class="cbp_tmlabel">
 
<div class="cbp_tmlabel">
 
<p>In order to increase the expression of the system,we remoulded the system in three palsmid.</p>
 
<p>In order to increase the expression of the system,we remoulded the system in three palsmid.</p>
Line 263: Line 260:
 
</li>
 
</li>
 
<li>
 
<li>
−
<time class="cbp_tmtime" datetime="2013-04-16 21:30"><span>July 12th-</span> <span>July 12th</span></time>
+
−
<div class="cbp_tmicon cbp_tmicon-earth"></div>
+
 
<div class="cbp_tmlabel">
 
<div class="cbp_tmlabel">
 
<p>We greeted Tito Jankowski visiting SZU-iGEM,who is the world's first bio hackerspaces BioCurious founder.</p>
 
<p>We greeted Tito Jankowski visiting SZU-iGEM,who is the world's first bio hackerspaces BioCurious founder.</p>
Line 270: Line 266:
 
</li>
 
</li>
 
<li>
 
<li>
−
<time class="cbp_tmtime" datetime="2013-04-16 21:30"><span>July 18th-</span> <span>July 18th</span></time>
+
−
<div class="cbp_tmicon cbp_tmicon-earth"></div>
+
 
<div class="cbp_tmlabel">
 
<div class="cbp_tmlabel">
 
<p>Began to distribute questionnaires Online<a href:"http://www.sojump.com/jq/5569949.aspx">http://www.sojump.com/jq/5569949.aspx</a></p>
 
<p>Began to distribute questionnaires Online<a href:"http://www.sojump.com/jq/5569949.aspx">http://www.sojump.com/jq/5569949.aspx</a></p>
Line 284: Line 279:
 
</li>
 
</li>
 
<li>
 
<li>
−
<time class="cbp_tmtime" datetime="2013-04-16 21:30"><span>July 30th-</span> <span>July 30th</span></time>
+
−
<div class="cbp_tmicon cbp_tmicon-earth"></div>
+
 
<div class="cbp_tmlabel">
 
<div class="cbp_tmlabel">
 
<p>Propaganda synthetic biology and iGEM to all students at the Cultural Festival of the Collage of Life Science.</p>
 
<p>Propaganda synthetic biology and iGEM to all students at the Cultural Festival of the Collage of Life Science.</p>
Line 291: Line 285:
 
</li>
 
</li>
 
<li>
 
<li>
−
<time class="cbp_tmtime" datetime="2013-04-16 21:30"><span>August 7th-</span> <span>August 15th</span></time>
+
−
<div class="cbp_tmicon cbp_tmicon-earth"></div>
+
 
<div class="cbp_tmlabel">
 
<div class="cbp_tmlabel">
 
<p>Finished some BioBricks:shTERT+GFP Composite(BBa_K1722009), TERT part(BBa_K1722002), shTERT part(BBa_K1722001),hUPII part(BBa_K1722000) and Rlu part(BBa_K1722005).</p>
 
<p>Finished some BioBricks:shTERT+GFP Composite(BBa_K1722009), TERT part(BBa_K1722002), shTERT part(BBa_K1722001),hUPII part(BBa_K1722000) and Rlu part(BBa_K1722005).</p>

Revision as of 07:30, 18 September 2015



Human practice




  • To discuss the decision of team project: CANCER SNIPER BLADDER

  • Finished the project system in shuttle vector

  • Transfected the two plasmid system in 5637 and T24 bladder cancer cells,and got a good result in Rluc(with amber mutation). Moreover,we got the control experiments data in human bladder fiber epithelial normal cells(HFC).

  • Improved the original BioBrick TERT (BBa_K1722001).

  • In order to increase the expression of the system,we remoulded the system in three palsmid.

  • We greeted Tito Jankowski visiting SZU-iGEM,who is the world's first bio hackerspaces BioCurious founder.

  • Began to distribute questionnaires Onlinehttp://www.sojump.com/jq/5569949.aspx

  • Transfected the three plasmid system in the T24 and 5637 bladder cancer cells,but its result was not so good.Therefore,we continued to use the two plasmid system.

  • Propaganda synthetic biology and iGEM to all students at the Cultural Festival of the Collage of Life Science.

  • Finished some BioBricks:shTERT+GFP Composite(BBa_K1722009), TERT part(BBa_K1722002), shTERT part(BBa_K1722001),hUPII part(BBa_K1722000) and Rlu part(BBa_K1722005).

  • Added GFP(with amber mutation) to the two plasmid system, and transfected the system in 5637 and T24 bladder cancer cells.

  • Finished some BioBricks:SV40(en) part(BBa_K1722006), SV40+Rlu Composite(BBa_K1722013), tRNA part(BBa_K1722004), SV40(en)+Rlu Composite(BBa_K1722012)

  • LZU-iGEM and SZU-iGEM made a whole day of cooperative communication.

  • The GFP gene transfection test was successful, and it proved that THE BLADDER CANCER SNIPER SYSTERM was functional.

  • Finished the rest of BioBricks:ShTERT+tRNA Composite(BBa_K1722011),hTERT+tRNA Composite（BBa_K1722010），AckRS part(BBa_K1722003),hUPll+AckRS Composite(BBa_K1722007)

  • Finished the rest of BioBricks:hUPll+AckRS Composite(BBa_K1722007),AckRS part(BBa_K1722003),ShTERT+tRNA Composite(BBa_K1722011),hTERT+tRNA Composite(BBa_K1722010)

  • Finished collecting BioBricks data, and edited in the wiki.https://2015.igem.org/Team:SZU_China/Parts

  • we visited the Shenzhen Cancer Rehabilitation Association,and made a thorough understanding about specific situation of cancer patients.

  • In order to prove the system's function and specificity, we made second GFP transfection test.The result indicated the system has a good function and specificity.

  • According to our experience, we convened cancer patients,and made a cancer patients communication,Which purpose is to give patients confidence and improve the difficult situation of group's treatment in china.